Skip to content

Self-Propelled Versus Standard Percutaneous Endoscopic Gastrojejunostomy(PEG-J); RCT

Comparison Outcomes and Complications of Self-Propelled vs. Standard Percutaneous Endoscopic Gastrojejunostomy (PEG-J); a Randomized Single Blind Clinical Trial

Status
Terminated
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01892267
Enrollment
19
Registered
2013-07-04
Start date
2013-09-06
Completion date
2014-12-31
Last updated
2017-05-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Feeding Tube

Keywords

PEGJ, PEG-J, Percutaneous Endoscopic Gastrostomy, Feeding tube, Gastroparesis, Acute pancreatitis, Stroke, Respiratory failure, GERD, Balloon, Self-propelled

Brief summary

Our main hypothesis is that self-propelled Percutaneous Endoscopic Gastrojejunostomy tube (PEG-J) that has a balloon on it's tip is associated with lower J-tube retrograde migration rate, and lower rates of short- and long-term complications when compared to standard PEGJ feeding tubes.

Interventions

DEVICEPEG-J placement

PEG-J placement

Sponsors

Johns Hopkins University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Consecutive adult patients (18-80 years of age) with need for post-pyloric feeding (patients unable to eat due to stroke, intubated patients with respiratory failure, patients with acute pancreatitis, etc). * Ability to give informed consent.

Exclusion criteria

* Unable to give informed consent * Pregnant or breastfeeding women (all women of child-bearing age will undergo urine pregnancy testing) * Acute gastrointestinal bleeding * Coagulopathy defined by prothrombin time \< 50% of control; PTT \> 50 sec, or INR \> 1.5), on chronic anticoagulation, or platelet count \<50,000 * Inability to tolerate sedated upper endoscopy due to cardio-pulmonary instability or other contraindication to endoscopy * Cirrhosis with portal hypertension, varices, and/or ascites * Allergy to egg

Design outcomes

Primary

MeasureTime frameDescription
Number of Participants With PEG-J Tube MigrationFrom date of placement up to 4 weeksNumber of participants in whom migration was assessed by X-ray at 4 weeks post-intervention.

Secondary

MeasureTime frameDescription
Patency of Feeding Tube2 yearsDetermine tube patency which is defined as time period between tube placement and need for re-intervention.
Technical SuccessIntra-proceduralSuccess of tube placement in the desired location as determined endoscopically.
Intervention TimeIntra-proceduralTime required from introduction of the upper endoscope until placement of the feeding tube.
Time to Repeat Endoscopy for Tube Replacement2 yearsIf repeate endocopy and tube placement are needed due to clogging or retrograde migration
Repeat Endoscopy for Feeding Tube Placement Due to Retrograde Tube Migration4 weeksPatiens who will have retrograde PEG-J tube migration will get repeat endoscopy for PEG-J tube placement
Gastrointestinal Quality of Life Index (GIQLI) Score3 monthGastrointestinal Quality of Life Index (GIQLI) score ranging from 0 (worst quality of life possible with severe digestive symptoms) to 144 (optimal quality of life without symptoms
Short-term ComplicationsOne weekShort-term complications will include stomal (Infection, erythema, bleeding, pain and secretion, etc) and tube (Clotting, dislocation, defect, aspiration, etc) complications detected in the first week.
Long-term Complications2 yearsLong-term complications will include stomal (Infection, erythema, bleeding, pain, secretion, abscess, etc) and tube (Clotting, dislocation, defect and aspiration, etc) complications detected more than one week after intervention.
Direct Cost2 yearsCost will be determined according to Medicare reimbursement of billed CPT codes. The cost of all related follow-up procedures will be included (e.g. cost of standard PEGJ in case of failed Self-propelled PEGJ feeding tube, cost of managing complications, cost of re-intervention in case of tube dysfunction, etc)
Difficulty of the ProcedureInra-proceduralScored by the endoscopist on a 10-point Visual Analogue Scale with zero being without difficulty and 10 being maximum difficulty. The lower the score, the better the outcome.

Countries

United States

Participant flow

Recruitment details

Patients were enrolled between 7/1/13 and 4/14/14 in an academic tertiary center

Participants by arm

ArmCount
Self-propelled PEGJ Feeding Tube
Patients in this arm will receive self-propelled balloon PEGJ tube. PEG-J placement: PEG-J placement
9
Standard PEGJ Feeding Tube
Patients in this arm will receive the standard commercially availabel PEGJ tube. PEG-J placement: PEG-J placement
10
Total19

Baseline characteristics

CharacteristicSelf-propelled PEGJ Feeding TubeStandard PEGJ Feeding TubeTotal
Age, Continuous62.22 years
STANDARD_DEVIATION 13.3
52 years
STANDARD_DEVIATION 10.68
56.84 years
STANDARD_DEVIATION 12.77
Gastrointestinal Quality of Life Index (GIQLI) score78.2 units on a scale
STANDARD_DEVIATION 27.1
69.1 units on a scale
STANDARD_DEVIATION 11.9
73.4 units on a scale
STANDARD_DEVIATION 20.5
Sex/Gender, Customized
Female
4 participants8 participants12 participants
Sex/Gender, Customized
Male
5 participants2 participants7 participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
5 / 93 / 10
serious
Total, serious adverse events
0 / 90 / 10

Outcome results

Primary

Number of Participants With PEG-J Tube Migration

Number of participants in whom migration was assessed by X-ray at 4 weeks post-intervention.

Time frame: From date of placement up to 4 weeks

ArmMeasureValue (NUMBER)
Self-propelled PEGJ Feeding TubeNumber of Participants With PEG-J Tube Migration3 participants
Standard PEGJ Feeding TubeNumber of Participants With PEG-J Tube Migration3 participants
Secondary

Difficulty of the Procedure

Scored by the endoscopist on a 10-point Visual Analogue Scale with zero being without difficulty and 10 being maximum difficulty. The lower the score, the better the outcome.

Time frame: Inra-procedural

ArmMeasureValue (MEAN)Dispersion
Self-propelled PEGJ Feeding TubeDifficulty of the Procedure6.2 units on a scaleStandard Deviation 3.8
Standard PEGJ Feeding TubeDifficulty of the Procedure7 units on a scaleStandard Deviation 2.2
Secondary

Direct Cost

Cost will be determined according to Medicare reimbursement of billed CPT codes. The cost of all related follow-up procedures will be included (e.g. cost of standard PEGJ in case of failed Self-propelled PEGJ feeding tube, cost of managing complications, cost of re-intervention in case of tube dysfunction, etc)

Time frame: 2 years

Population: Study terminated prematurely, so that the appropriate follow-up data was not collected.

Secondary

Gastrointestinal Quality of Life Index (GIQLI) Score

Gastrointestinal Quality of Life Index (GIQLI) score ranging from 0 (worst quality of life possible with severe digestive symptoms) to 144 (optimal quality of life without symptoms

Time frame: 3 month

Population: The discrepancy between the number of analyzed patients and the number of patients in the Participant Flow section is due to the fact that only 5 patients had a completed GIQLI questionnaire at 3-month follow-up.

ArmMeasureValue (MEDIAN)
Self-propelled PEGJ Feeding TubeGastrointestinal Quality of Life Index (GIQLI) Score106 units on a scale
Standard PEGJ Feeding TubeGastrointestinal Quality of Life Index (GIQLI) Score75 units on a scale
Secondary

Intervention Time

Time required from introduction of the upper endoscope until placement of the feeding tube.

Time frame: Intra-procedural

ArmMeasureValue (MEAN)Dispersion
Self-propelled PEGJ Feeding TubeIntervention Time17.2 minuteStandard Deviation 12.3
Standard PEGJ Feeding TubeIntervention Time28.7 minuteStandard Deviation 13.6
Secondary

Long-term Complications

Long-term complications will include stomal (Infection, erythema, bleeding, pain, secretion, abscess, etc) and tube (Clotting, dislocation, defect and aspiration, etc) complications detected more than one week after intervention.

Time frame: 2 years

Population: Study terminated prematurely, so that the appropriate follow-up data was not collected.

Secondary

Patency of Feeding Tube

Determine tube patency which is defined as time period between tube placement and need for re-intervention.

Time frame: 2 years

Population: Study terminated prematurely, so that the appropriate follow-up data was not collected.

Secondary

Repeat Endoscopy for Feeding Tube Placement Due to Retrograde Tube Migration

Patiens who will have retrograde PEG-J tube migration will get repeat endoscopy for PEG-J tube placement

Time frame: 4 weeks

ArmMeasureValue (NUMBER)
Self-propelled PEGJ Feeding TubeRepeat Endoscopy for Feeding Tube Placement Due to Retrograde Tube Migration3 participants
Standard PEGJ Feeding TubeRepeat Endoscopy for Feeding Tube Placement Due to Retrograde Tube Migration3 participants
Secondary

Short-term Complications

Short-term complications will include stomal (Infection, erythema, bleeding, pain and secretion, etc) and tube (Clotting, dislocation, defect, aspiration, etc) complications detected in the first week.

Time frame: One week

ArmMeasureValue (NUMBER)
Self-propelled PEGJ Feeding TubeShort-term Complications2 participants
Standard PEGJ Feeding TubeShort-term Complications3 participants
Secondary

Technical Success

Success of tube placement in the desired location as determined endoscopically.

Time frame: Intra-procedural

ArmMeasureValue (NUMBER)
Self-propelled PEGJ Feeding TubeTechnical Success8 procedure
Standard PEGJ Feeding TubeTechnical Success10 procedure
Secondary

Time to Repeat Endoscopy for Tube Replacement

If repeate endocopy and tube placement are needed due to clogging or retrograde migration

Time frame: 2 years

Population: Study terminated prematurely, so that the appropriate follow-up data was not collected.

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026